UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000008072
Receipt number R000009508
Scientific Title Multi-omics analysis of esophageal cancer for elucidating carcinogenic mechanisms and identifying diagnostic markers
Date of disclosure of the study information 2012/05/31
Last modified on 2020/12/06 13:05:33

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Multi-omics analysis of esophageal cancer for elucidating carcinogenic mechanisms and identifying diagnostic markers

Acronym

Multi-omics analysis of esophageal cancer

Scientific Title

Multi-omics analysis of esophageal cancer for elucidating carcinogenic mechanisms and identifying diagnostic markers

Scientific Title:Acronym

Multi-omics analysis of esophageal cancer

Region

Japan


Condition

Condition

esophageal cancer

Classification by specialty

Gastrointestinal surgery

Classification by malignancy

Malignancy

Genomic information

YES


Objectives

Narrative objectives1

Omics-based analysis of esophageal cancer for investigating carcinogenesis mechanism and detecting diagnostic markers

Basic objectives2

Others

Basic objectives -Others

Omics-based analysis of esophageal cancer for investigating carcinogenesis mechanism and detecting diagnostic markers

Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Relationship between results of omics-based analysis and cliniophathological factors

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patient who will undergo radical surgery
Patient who gives his/her informed consent to participating in this research
Patient whose tumor is large enough for pathological diagnosis after collecting sample

Key exclusion criteria

Patient whose HBs-Ag test, HCV-Ab test , or TPHA test is positive
Patient who has received steroids systemically
Patient who suffers from systemic infectious disease
Patient who suffers from active multiple primary cancers
Patient who has no ability to judge

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Soji
Middle name
Last name Ozawa

Organization

Tokai University School of Medicine

Division name

Department of Gastroenterological Surgery

Zip code

259-1193

Address

143 Shimokasuya, Isehara, Kanagawa, 259-1193

TEL

0463-93-1121

Email

sozawa@tokai.ac.jp


Public contact

Name of contact person

1st name Soji
Middle name
Last name Ozawa

Organization

Tokai University School of Medicine

Division name

Department of Gastroenterological Surgery

Zip code

259-1193

Address

143 Shimokasuya, Isehara, Kanagawa, 259-1193

TEL

0463-93-1121

Homepage URL


Email

tokai.eso@tokai-u.jp


Sponsor or person

Institute

Department of Gastroenterological Surgery
Tokai University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Department of Gastroenterological Surgery
Tokai University School of Medicine

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Institutional Review Board for Clinical Research, Tokai University

Address

Shimokasuya 143, Isehara, Kanagawa, JAPAN

Tel

0463-93-1121

Email

tokai-rinsho@ml.tokai-u.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

東海大学医学部付属病院(神奈川県)


Other administrative information

Date of disclosure of the study information

2012 Year 05 Month 31 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2012 Year 02 Month 15 Day

Date of IRB

2012 Year 04 Month 27 Day

Anticipated trial start date

2012 Year 05 Month 01 Day

Last follow-up date

2018 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

The registration stared in May 2012.


Management information

Registered date

2012 Year 05 Month 31 Day

Last modified on

2020 Year 12 Month 06 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000009508


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name